Diamyd tries to salvage something from clinical wreck
Diamyd Medical will continue with a clinical trial of its gene therapy designed to protect insulin-producing cells in diabetes patients, despite major errors invalidating the study.
Archives for June 18, 2007
Bayer cuts swathe through pipeline
In the inevitable reshuffle that comes after a major acquisition, Bayer's healthcare division has today announced plans to cut 30 per cent of its drug pipeline.
CORVUS throws blood brain barrier a curve ball
Researchers have developed a new way to deliver drugs into the brains of mice, which could herald a new dawn for the sufferers of brain diseases such as Alzheimer's.
Synexus 'confident' despite profit drop
UK-based Synexus was optimistic last week when it announced its preliminary financial results for the year, despite a plummeting operating profit.
Cosmo gets to the bottom of IBD
Cosmo Pharmaceuticals is cementing its place in the inflammatory bowel disease (IBD) drug market with eight new drugs in various stages of reformulation using the company's cutting-edge MMX technology, the company announced recently.
Aptuit splurges $100m in India
US firm Aptuit has announced it will invest $100m (€75m) in India-based Laurus Labs to form a new joint venture - just a few months after splurging a similar amount to expand its capabilities.
Patient registries on the up
Patient registries are becoming increasingly popular as their value is now being recognised, according to an industry expert.
Asia beckons DSM anti-infectives
Dutch ingredients firm DSM has announced plans to carve out its anti-infectives business and boost its presence in Asian markets following a review of the active ingredient unit.
Merck-Serono pushes next generation hGH product
In a bid to maintain its position in the human growth hormone (hGH) market and offer new solutions to patients, Merck-Serono has teamed up with a US firm to develop a novel growth hormone product that could offer significant dosing advantages.
Biobanking on the future
With the world's largest medical study rolling out across the UK, LabTechnologist.com explores the problems of biobanking with Dutch biosample storage experts, Micronic.
Roche snaps up NimbleGen
Roche Diagnostics has strengthened its position in the genomics field with the acquisition of DNA microarray expert NimbleGen in a deal worth $272.5m (€203m).